Page 52 - AN-1-3

Advanced Neurology The diagnosis and treatment of anti-LGI1 autoimmune encephalitis

https://doi.org/10.3389/fimmu.2018.01931 https://doi.org/10.1212/NXI.0000000000000161
29. Asioli GM, Muccioli L, Barone V, et al., 2022, Anti-LGI1 40. Striano P, 2011, Faciobrachial dystonic attacks: Seizures
encephalitis following COVID-19 vaccination: A case series. or movement disorder? Ann Neurol, 70: 179–180; author
J Neurol, 269: 5720–5723. reply 180.
https://doi.org/10.1007/s00415-022-11234-4 https://doi.org/10.1002/ana.22470
30. Zlotnik Y, Gadoth A, Abu-Salameh I, et al., 2021, Case 41. Barajas RF, Collins DE, Cha S, et al., 2010, Adult-onset drug-
report: Anti-LGI1 encephalitis following COVID-19 refractory seizure disorder associated with anti-voltage-
vaccination. Front Immunol, 12: 813487. gated potassium-channel antibody. Epilepsia, 51: 473–477.
https://doi.org/10.3389/fimmu.2021.813487 https://doi.org/10.1111/j.1528-1167.2009.02287.x
31. Thompson J, Bi M, Murchison AG, et al., 2018, The 42. Liu X, Shan W, Zhao X, et al., 2020, The clinical value of (18)
importance of early immunotherapy in patients with F-FDG-PET in autoimmune encephalitis associated with
faciobrachial dystonic seizures. Brain, 141: 348–356. LGI1 antibody. Front Neurol, 11: 418.
https://doi.org/10.1093/brain/awx323 https://doi.org/10.3389/fneur.2020.00418
32. Van Sonderen A, Thijs RD, Coenders EC, et al., 2016, 43. Liu X, Han Y, Yang L, et al., 2020, The exploration of the
Anti-LGI1 encephalitis: Clinical syndrome and long-term spectrum of motor manifestations of anti-LGI1 encephalitis
follow-up. Neurology, 87: 1449–1456. beyond FBDS. Seizure, 76: 22–27.
https://doi.org/10.1212/WNL.0000000000003173 https://doi.org/10.1016/j.seizure.2019.12.023
44. Teng Y, Li T, Yang Z, et al., 2021, Clinical features and
33. Simabukuro MM, Nobrega PR, Pitombeira M, et al., 2016,
The importance of recognizing faciobrachial dystonic therapeutic effects of anti-leucine-rich glioma inactivated 1
seizures in rapidly progressive dementias. Dement encephalitis: A systematic review. Front Neurol, 12: 791014.
Neuropsychol, 10: 351–357. https://doi.org/10.3389/fneur.2021.791014
https://doi.org/10.1590/s1980-5764-2016dn1004016 45. Fauser S, Talazko J, Wagner K, et al., 2005, FDG-PET
and MRI in potassium channel antibody-associated non-
34. Gastaldi M, Thouin A, Vincent A, et al., 2016,
Antibody-mediated autoimmune encephalopathies and paraneoplastic limbic encephalitis: Correlation with
immunotherapies. Neurotherapeutics, 13: 147–162. clinical course and neuropsychology. Acta Neurol Scand,
111: 338–343.
https://doi.org/10.1007/s13311-015-0410-6
https://doi.org/10.1111/j.1600-0404.2005.00406.x
35. Navarro V, Kas A, Apartis E, et al., 2016, Motor cortex and 46. Lv RJ, Sun ZR, Cui T, et al., 2014, Temporal lobe epilepsy
hippocampus are the two main cortical targets in LGI1- with amygdala enlargement: A subtype of temporal lobe
antibody encephalitis. Brain, 139(Pt 4): 1079–1093.
epilepsy. BMC Neurol, 14: 194.
https://doi.org/10.1093/brain/aww012
https://doi.org/10.1186/s12883-014-0194-z
36. Irani SR, Buckley C, Vincent A, et al., 2008, Immunotherapy- 47. Miller TD, Chong TT, Davies AM, et al., 2017, Focal
responsive seizure-like episodes with potassium channel CA3 hippocampal subfield atrophy following LGI1
antibodies. Neurology, 71: 1647–1648. VGKC-complex antibody limbic encephalitis. Brain,
https://doi.org/10.1212/01.wnl.0000326572.93762.51 140: 1212–1219.
37. Irani SR, Michell AW, Lang B, et al., 2011, Faciobrachial https://doi.org/10.1093/brain/awx070
dystonic seizures precede Lgi1 antibody limbic encephalitis. 48. Szots M, Blaabjerg M, Orsi G, et al., 2017, Global brain
Ann Neurol, 69: 892–900. atrophy and metabolic dysfunction in LGI1 encephalitis:
https://doi.org/10.1002/ana.22307 A prospective multimodal MRI study. J Neurol Sci,
376: 159–165.
38. Irani SR, Stagg CJ, Schott JM, et al., 2013, Faciobrachial
dystonic seizures: The influence of immunotherapy on https://doi.org/10.1016/j.jns.2017.03.020
seizure control and prevention of cognitive impairment in a 49. Finke C, Pruss H, Heine J, et al., 2017, Evaluation of cognitive
broadening phenotype. Brain, 136(Pt 10): 3151–3162. deficits and structural hippocampal damage in encephalitis
https://doi.org/10.1093/brain/awt212 with leucine-rich, glioma-inactivated 1 antibodies. JAMA
Neurol, 74: 50–59.
39. Flanagan EP, Kotsenas AL, Britton JW, et al., 2015,
Basal ganglia T1 hyperintensity in LGI1-autoantibody https://doi.org/10.1001/jamaneurol.2016.4226
faciobrachial dystonic seizures. Neurol Neuroimmunol 50. Bien CG, Elger CE, 2007, Limbic encephalitis: A cause of
Neuroinflamm, 2: e161. temporal lobe epilepsy with onset in adult life. Epilepsy

Volume 1 Issue 3 (2022) 9 https://doi.org/10.36922/an.v1i3.237